The Complete Guide to AI Clinical Trials (2026): Saama, Unlearn.AI, Deep 6 AI, Medidata & Tempus

Bringing a single new drug to market takes more than a decade on average and billions of dollars—most of it consumed by clinical trials. Patients are hard to recruit, data management is cumbersome, and trials drag on. In 2026, AI-driven trial transformation is spreading rapidly to address these challenges. This article surveys the leading AI clinical trial platforms.

What are AI clinical trials?

AI clinical trials embed AI and machine learning into each step of a trial—protocol design, patient recruitment, data collection and cleaning, safety monitoring, and analysis—to shorten timelines, cut costs, and improve data quality. Technologies that upend conventional trial wisdom are emerging, such as patient discovery via electronic health record (EHR) analysis and AI-generated "synthetic control arms."

Saama

Saama is a leading platform for automating clinical data management, cleaning, and analysis with AI. It integrates and quality-checks trial data arriving from multiple sources in real time, dramatically shortening time-to-database-lock. It is widely adopted as a data management backbone by major pharmaceutical companies.

Unlearn.AI

Unlearn.AI is known for "digital twins" and synthetic control arms. It builds an AI-predicted digital twin of each patient's disease progression and replaces part of the control group, reducing the number of subjects needed and allocating more patients to the active arm. As a way to reduce patient burden while improving trial efficiency, it is under active discussion with regulators.

Deep 6 AI

Deep 6 AI is a recruitment-focused platform that uses natural language processing to analyze EHRs and rapidly find patients who match a trial's inclusion/exclusion criteria. It shortens candidate identification—previously weeks to months—to minutes, accelerating enrollment, the biggest bottleneck in trials.

Medidata AI / Tempus / QuantHealth

Medidata (part of Dassault Systèmes) is the leading trial management vendor (EDC/CTMS), offering AI features (synthetic control arms, site selection, risk-based monitoring) powered by vast historical trial data. Tempus integrates genomic and clinical data, with particular strength in precision oncology and trial matching. QuantHealth is an emerging company drawing attention for "clinical trial simulation" that predicts trial outcomes in advance.

Decentralized clinical trials (DCT)

Advancing alongside AI are decentralized clinical trials. Wearables, remote monitoring, and online consent let patients participate from home without visiting a hospital. AI handles the analysis and anomaly detection of large volumes of remote data, underpinning the feasibility of DCT.

Common use cases

• Patient recruitment: Rapid candidate discovery via EHR analysis (Deep 6 AI).
• Data management: Multi-source integration, cleaning, and faster database lock (Saama).
• Control-arm efficiency: Synthetic control arms and digital twins (Unlearn.AI/Medidata).
• Trial design: Protocol optimization via outcome simulation (QuantHealth).

How to choose

• Automating clinical data management and analysis: Saama.
• Digital twins and synthetic control arms: Unlearn.AI.
• Patient recruitment via EHR analysis: Deep 6 AI.
• Comprehensive trial management backbone: Medidata.
• Oncology / precision-medicine trial matching: Tempus.

Implementation notes

Clinical trials are an extremely regulated domain tied directly to patient safety and efficacy evaluation. Using AI requires compliance with the guidance of regulators such as the FDA, EMA, and PMDA (GxP, data integrity, acceptability of synthetic control arms). Always verify model explainability and validatability, patient data privacy (HIPAA/GDPR), and algorithmic bias checks. Synthetic control arms and digital twins are powerful, but their regulatory acceptance is still evolving and presupposes prior consultation with authorities.

Conclusion

AI clinical trials can accelerate the biggest bottleneck in drug development while reducing patient burden and improving data quality. For data management, Saama; for synthetic control arms, Unlearn.AI; for patient recruitment, Deep 6 AI; for a comprehensive backbone, Medidata. Prioritizing regulatory compliance and validatability, and rolling out in phases, is the key to success.